Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04408222 · ClinicalTrials.gov registry record
Awake Proning in COVID-19 Patients With Hypoxemic Respiratory Failure
A clinical trial of Coronavirus Infection and Oxygen Deficiency, sponsored by Columbia University.
- Completed
- Registry status
- 29
- Enrollment target
- 1
- Study location
NCT04408222 is a study of Coronavirus Infection and Oxygen Deficiency that has completed, run by Columbia University. The registered enrollment target is 29 participants, below the 260-participant average among 12 other Coronavirus Infection trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04408222, a study of Coronavirus Infection and Oxygen Deficiency, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- 29 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to retrospectively review clinical data to determine whether awake proning improves oxygenation in spontaneously breathing patients with COVID-19 severe hypoxemic respiratory failure.
Conditions Studied
Interventions
- OTHER Awake proning
Study Locations (1)
New York
- Columbia University Irving Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2020-04-16 |
| Est. Completion | 2022-03-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04408222
The ClinicalTrials.gov registry entry for NCT04408222 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 260-participant average among 12 other Coronavirus Infection trials with a reported enrollment target (89% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Coronavirus Infection appearing as the primary indexed condition, and to 1 intervention - of which Awake proning is the first listed.
NCT04408222 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04408222 about?
NCT04408222 is a clinical study titled "Awake Proning in COVID-19 Patients With Hypoxemic Respiratory Failure". The purpose of this study is to retrospectively review clinical data to determine whether awake proning improves oxygenation in spontaneously breathing patients with COVID-19 severe hypoxemic respiratory failure.
What is the current status of trial NCT04408222?
This trial is currently completed. The enrollment target is 29 participants. The study started on 2020-04-16. Estimated completion is 2022-03-06.
What conditions does trial NCT04408222 study?
This clinical trial studies the following conditions: Coronavirus Infection, Oxygen Deficiency.
What interventions are being tested in trial NCT04408222?
The interventions under investigation include: Awake proning (OTHER).
Who is sponsoring clinical trial NCT04408222?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04408222 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronavirus Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Convalescent Plasma Collection and Treatment in Pediatrics and Adults
RECRUITING · Phase 3
-
ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers
RECRUITING
-
Post COVID-19 Biorepository
RECRUITING
-
COVID-19 and Lactating Mothers
COMPLETED
-
Index Individuals in SARS-CoV-2 Prevention Research Studies (COVID-19 Index Individuals Companion Study)
COMPLETED
-
COVFIS-HOME: COVID-19 Pilot Study of Fisetin to Alleviate Dysfunction and Decrease Complications
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.